Skip to main content

Table 1 Comparison of characteristics according to ACI in all patients

From: Is elective inguinal radiotherapy necessary for locally advanced rectal adenocarcinoma invading anal canal?

  

With ACI (n = 192)

Without ACI (n = 1,054)

p -value

Age (yr)

Mean ± SD

57.6 ± 11.3

58.2 ± 10.8

0.462

Gender

Male

114 (59.4)

718 (68.1)

0.018

 

Female

78 (40.6)

336 (31.9)

 

Distance from anal verge (cm)

Mean ± SD

2.0 ± 0.9

6.9 ± 2.1

<0.001

Histological grade*

Low

171 (90.0)

989 (96.2)

<0.001

 

High

19 (10.0)

39 (3.8)

 
 

(Not specified = 28)

   

Clinical stage

cStage II

42 (21.9)

213 (20.2)

0.599

 

cStage III

150 (78.1)

841 (79.8)

 

Pathological stage

ypStage 0

26 (13.5)

104 (9.9)

0.001

 

ypStage I

47 (24.5)

176 (16.7)

 
 

pStage II/ypStage II

54 (28.1)

299 (28.4)

 
 

pStage III/ypStage III

65 (33.9)

475 (45.1)

 

CRT timing

Preoperative CRT

168 (87.5)

709 (67.3)

<0.001

 

Postoperative CRT

24 (12.5)

345 (32.7)

 

Concurrent chemotherapy

Fluoropyrimidine alone

166 (86.5)

960 (91.8)

0.018

 

Irinotecan or oxaliplatin-based

26 (13.5)

86 (8.2)

 
 

(None = 8)

   

Surgery

Sphincter-sparing surgery

64 (33.3)

1,016 (96.4)

<0.001

 

Abdominoperineal resection

128 (66.7)

38 (3.6)

 

CRM

Negative (>0.1 cm)

154 (80.2)

890 (85.3)

0.071

 

Positive (≤0.1 cm)

38 (19.8)

153 (14.7)

 
 

(Not specified = 11)

   

Postoperative chemotherapy

Yes

175 (91.1)

962 (91.3)

0.955

 

No

17 (8.9)

92 (8.7)

 
  1. Abbreviations: ACI anal canal invasion, SD standard deviation, CRT chemoradiotherapy, CRM circumferential resection margin.
  2. *Evaluated by pretreatment diagnostic biopsy. Low indicates well or moderately differentiated; high indicates poorly differentiated, mucinous, or signet ring cell carcinoma.
  3. Including patients who did not finish the planned chemotherapy.
  4. Chi-square test, linear-by-linear association, or t-test.